Roth MKM Maintains Buy on TFF Pharmaceuticals, Lowers Price Target to $44
Roth MKM Maintains Buy on TFF Pharmaceuticals, Lowers Price Target to $44
Roth MKM 維持對TFF Pharmicals的買入,將目標股價下調至44美元
Roth MKM analyst Jonathan Aschoff maintains TFF Pharmaceuticals (NASDAQ:TFFP) with a Buy and lowers the price target from $56 to $44.
羅斯MKM分析師喬納森·阿肖夫維持TFF Pharmicals(納斯達克股票代碼:TFFP)的買入並將目標股價從56美元下調至44美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。